Biogaia AB
STO:BIOG B
Biogaia AB
STO:BIOG B
Price:
113.6 SEK
-0.44%
Market Closed
Updated:
May 7, 2024
Biogaia AB
Cash from Operating Activities
|
Biogaia AB
Cash from Operating Activities Peer Comparison
Comparables:
BONEX
VITR
PROB
SOBI
BIOA B
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Biogaia AB
STO:BIOG B
|
Cash from Operating Activities
kr426m
|
CAGR 3-Years
24%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Cash from Operating Activities
-kr18.3m
|
CAGR 3-Years
43%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Cash from Operating Activities
kr795m
|
CAGR 3-Years
18%
|
CAGR 5-Years
18%
|
CAGR 10-Years
22%
|
|
|
Probi AB
STO:PROB
|
Cash from Operating Activities
kr85.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
13%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Cash from Operating Activities
kr4.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
16%
|
CAGR 10-Years
37%
|
|
|
BioArctic AB
STO:BIOA B
|
Cash from Operating Activities
kr309.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Biogaia AB's Cash from Operating Activities?
Cash from Operating Activities
426m
SEK
426m
SEK
Based on the financial report for Dec 31, 2023, Biogaia AB's Cash from Operating Activities amounts to 426m SEK.
What is Biogaia AB's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
18%
18%
Over the last year, the Cash from Operating Activities growth was 34%. The average annual Cash from Operating Activities growth rates for Biogaia AB have been 24% over the past three years , 18% over the past five years .
You don't have any saved screeners yet
